ID: ALA468540

Max Phase: Preclinical

Molecular Formula: C14H7F4N

Molecular Weight: 265.21

Molecule Type: Small molecule

Representations

Canonical SMILES:  N#Cc1ccc(-c2ccc(C(F)(F)F)c(F)c2)cc1

Standard InChI:  InChI=1S/C14H7F4N/c15-13-7-11(5-6-12(13)14(16,17)18)10-3-1-9(8-19)2-4-10/h1-7H

Standard InChI Key:  GGTNFQNNBXFPBX-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 265.21

Molecular Weight (Monoisotopic): 265.0515

AlogP: 4.38

#Rotatable Bonds: 1

Polar Surface Area: 23.79

Molecular Species:

HBA: 1

HBD: 0

#RO5 Violations: 0

HBA (Lipinski): 1

HBD (Lipinski): 0

#RO5 Violations (Lipinski): 0

CX Acidic pKa:

CX Basic pKa:

CX LogP: 4.50

CX LogD: 4.50

Aromatic Rings: 2

Heavy Atoms: 19

QED Weighted: 0.70

Np Likeness Score: -1.30

References

1. Matsuno K, Sawada J, Sugimoto M, Ogo N, Asai A..  (2009)  Bis(hetero)aryl derivatives as unique kinesin spindle protein inhibitors.,  19  (4): [PMID:19167222] [10.1016/j.bmcl.2009.01.018]

Source

Source(1):

• Scientific Literature